Stock Events

Stock Events

Cocrystal Pharma (8CC.F) Q1 2026 Earnings

31MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.45

-0.35

-0.24

-0.14

Details

Expected EPS

-0.15125249999999998

Actual EPS

-0.138288

Surprise EPS

0.01

Surprise Percent

+8.57%

Description

Cocrystal Pharma (8CC.F) has reported earnings of -0.138288 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.